SevenBridge Financial Group’s Moderna MRNA Stock Holding History

SevenBridge Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,621	Closed	-$1.31M	–	154
2022 Q1	$1.31M	Buy	7,621 +6,176	+427%	+$1.04M	0.46%	57
2021 Q4	$367K	Sell	1,445 -1,519	-51%	-$444K	0.11%	125
2021 Q3	$1.14M	Sell	2,964 -38	-1%	-$14K	0.38%	70
2021 Q2	$705K	Buy	3,002 +1,375	+85%	+$246K	0.23%	99
2021 Q1	$213K	Buy	+1,627	New	+$236K	0.08%	150
2019 Q3	–	Sell	-500	Closed	-$7K	–	418
2019 Q2	$7K	Hold	500	–	–	﹤0.01%	490
2019 Q1	$10K	Sell	500 -775	-61%	-$14.4K	﹤0.01%	417
2018 Q4	$19K	Buy	+1,275	New	+$21K	0.01%	311

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SevenBridge Financial Group's MRNA Position: Q2 2022 in Review

SevenBridge Financial Group sold out of Moderna (MRNA) in Q2 2022, closing a stake of 7,621 shares — an estimated $1.31M sold.

SevenBridge Financial Group first reported a position in MRNA in Q4 2018 and held it in 8 quarters. The position peaked at $1.31M in Q1 2022. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

SevenBridge Financial Group reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
SevenBridge Financial Group sold 7,621 Moderna shares in Q2 2022, an estimated $1.31M.
SevenBridge Financial Group first reported a position in Moderna in Q4 2018 and held it in 8 quarters.
SevenBridge Financial Group's Moderna position peaked at $1.31M in Q1 2022.
982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on SevenBridge Financial Group's 13F filing for Q2 2022, filed 12 Jul 2022.